[

    {
        "article_link": "https://doi.org/10.3389/fonc.2023.1186858",
        "data": [
            {
                "id": "data_1",
                "omics": "Transcriptomics",
                "link": "https://xenabrowser.net/datapages/",
                "format": "Processed Data",
                "source": "University of California Santa Cruz (UCSC)",
                "public_id": "TCGA-BRCA RNA-seq"
            },
            {
                "id": "data_2",
                "omics": "Genomics",
                "link": "https://xenabrowser.net/datapages/",
                "format": "Processed Data",
                "source": "University of California Santa Cruz (UCSC)",
                "public_id": "TCGA-BRCA CNV"
            },
            {
                "id": "data_3",
                "omics": "Epigenomics (DNA Methylation)",
                "link": "https://xenabrowser.net/datapages/",
                "format": "Processed Data",
                "source": "University of California Santa Cruz (UCSC)",
                "public_id": "TCGA-BRCA DNA Methylation 450k"
            },
            {
                "id": "data_4",
                "omics": "Transcriptomics",
                "link": "http://www.ncbi.nlm.nih.gov/geo/",
                "format": "Processed Data",
                "source": "Gene Expression Omnibus (GEO)",
                "public_id": "GSE7390"
            },
            {
                "id": "data_5",
                "omics": "Transcriptomics",
                "link": "http://www.ncbi.nlm.nih.gov/geo/",
                "format": "Processed Data",
                "source": "Gene Expression Omnibus (GEO)",
                "public_id": "GSE20685"
            },
            {
                "id": "data_6",
                "omics": "Transcriptomics",
                "link": "http://www.ncbi.nlm.nih.gov/geo/",
                "format": "Processed Data",
                "source": "Gene Expression Omnibus (GEO)",
                "public_id": "GSE103091"
            },
            {
                "id": "data_7",
                "omics": "Single-cell Transcriptomics",
                "link": "http://www.ncbi.nlm.nih.gov/geo/",
                "format": "Processed Data",
                "source": "Gene Expression Omnibus (GEO)",
                "public_id": "GSE176078"
            }
        ],
        "analyses": [
            {
                "id": "analysis_1",
                "analysis_name": "Hub genes screening",
                "analysis_data": ["data_1", "data_2", "data_3"],
                "label": {"pcombined": ["<0.01"]}
            },
            {
                "id": "analysis_2",
                "analysis_name": "Construction of RS signature",
                "analysis_data": ["analysis_1"],
                "label": {"risk_subgroups": ["high-risk", "low-risk"]}
            },
            {
                "id": "analysis_3",
                "analysis_name": "Validation of RS signature",
                "analysis_data": ["data_4", "data_5", "data_6"],
                "label": {"risk_subgroups": ["high-risk", "low-risk"]}
            },
            {
                "id": "analysis_4",
                "analysis_name": "Stratified analysis by disease stages",
                "analysis_data": ["analysis_2"],
                "label": {"stages": ["I/II", "III/IV"]}
            },
            {
                "id": "analysis_5",
                "analysis_name": "Stratified analysis by molecular subtypes",
                "analysis_data": ["analysis_2"],
                "label": {"subtypes": ["ER-negative/positive", "PR-negative/positive", "HER2-negative/positive"]}
            },
            {
                "id": "analysis_6",
                "analysis_name": "Single-cell analysis",
                "analysis_data": ["data_7"],
                "label": {"risk_subgroups": ["high-risk", "low-risk"]}
            },
            {
                "id": "analysis_7",
                "analysis_name": "Immune checkpoint analysis",
                "analysis_data": ["analysis_2"],
                "label": {"risk_subgroups": ["high-risk", "low-risk"]}
            },
            {
                "id": "analysis_8",
                "analysis_name": "Drug sensitivity analysis",
                "analysis_data": ["analysis_2"],
                "label": {"risk_subgroups": ["high-risk", "low-risk"]}
            }
        ],
        "results": [
            {
                "analysis_id": "analysis_2",
                "metrics": "AUC",
                "value": "0.738 (3 years), 0.701 (5 years)",
                "features": ["C15orf52", "C1orf228", "CEL", "FUZ", "PAK6", "SIRPG"]
            },
            {
                "analysis_id": "analysis_3",
                "metrics": "AUC",
                "value": "0.675 (3 years, validation set 1), 0.657 (5 years, validation set 1), 0.690 (3 years, validation set 2), 0.609 (5 years, validation set 2)",
                "features": ["C15orf52", "C1orf228", "CEL", "FUZ", "PAK6", "SIRPG"]
            },
            {
                "analysis_id": "analysis_4",
                "metrics": "AUC",
                "value": "0.766 (3 years, stages I/II), 0.712 (5 years, stages I/II), 0.689 (3 years, stages III/IV), 0.708 (5 years, stages III/IV)",
                "features": ["C15orf52", "C1orf228", "CEL", "FUZ", "PAK6", "SIRPG"]
            },
            {
                "analysis_id": "analysis_5",
                "metrics": "AUC",
                "value": "0.675 (3 years, ER-negative), 0.751 (3 years, ER-positive), 0.714 (3 years, PR-negative), 0.708 (3 years, PR-positive), 0.711 (3 years, HER2-negative), 0.795 (3 years, HER2-positive)",
                "features": ["C15orf52", "C1orf228", "CEL", "FUZ", "PAK6", "SIRPG"]
            },
            {
                "analysis_id": "analysis_6",
                "metrics": "Cellular composition",
                "value": "Lower lymphocyte infiltration in high-risk group",
                "features": ["T cells", "MSC (mesenchymal stem cells)"]
            },
            {
                "analysis_id": "analysis_7",
                "metrics": "Expression levels",
                "value": "Downregulated immune checkpoints in high-risk group",
                "features": ["BTLA", "CD200R1", "CD27", "CD28", "CD40", "CD40LG", "CTLA4", "HLA-DRB1", "IL2RB", "LAG3", "PDCD1", "TIGIT", "TNFRSF14"]
            },
            {
                "analysis_id": "analysis_8",
                "metrics": "IC50",
                "value": "Lower sensitivity to 81 drugs in high-risk group, higher sensitivity to BI2536 in high-risk group",
                "features": ["BI2536", "Camptothecin", "Epirubicin", "Vinnorelbine"]
            }
        ]
    }

]
